Skip to Content

Argatroban Pregnancy and Breastfeeding Warnings

Argatroban is also known as: Acova

Medically reviewed on July 16, 2018

Argatroban Pregnancy Warnings

Argatroban has been assigned to pregnancy category B by the FDA. Animal studies have failed to reveal evidence of fetal harm. There are no controlled data in human pregnancy. Argatroban should only be given during pregnancy when need has been clearly established.

See references

Argatroban Breastfeeding Warnings

There are no data on the excretion of argatroban into human milk. The manufacturer recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Argatroban has been detected in breast milk in animal studies.

See references

References for pregnancy information

  1. "Product Information. Acova (argatroban)" SmithKline Beecham, Philadelphia, PA.

References for breastfeeding information

  1. "Product Information. Acova (argatroban)" SmithKline Beecham, Philadelphia, PA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide